Go to the international site...
... or select your country:
© 2010, Bayer Schering Pharma AG This website is intended to provide information to an international audience outside the USA and UK. Last updated on 9th March 2010
Examine impressive results for simple, uncomplicated clot prevention
See extensive results for the most studied anticoagulant of its kind
View the direct inhibition of Factor Xa, an active area of research
Thromboembolic disorders pose life threatening risks to millions of patients
Connect with a world of events devoted to thromboembolic research
Search